Despite initial enthusiasm, these assays have struggled to carve out a significant market, hampered by concerns about test performance and the lack of a clear role in clinical decision-making.
from Vendors search for new options after COVID serology fails to meet early hype
https://ift.tt/2HhrJM9
https://ift.tt/eA8V8J
No comments:
Post a Comment